1. Home
  2. BLMN vs LXRX Comparison

BLMN vs LXRX Comparison

Compare BLMN & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$6.98

Market Cap

586.3M

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.27

Market Cap

541.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
LXRX
Founded
1988
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
586.3M
541.5M
IPO Year
2012
2000

Fundamental Metrics

Financial Performance
Metric
BLMN
LXRX
Price
$6.98
$1.27
Analyst Decision
Sell
Buy
Analyst Count
7
5
Target Price
$8.29
$3.23
AVG Volume (30 Days)
2.1M
1.5M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
9.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,952,793,000.00
$70,864,000.00
Revenue This Year
$2.19
$56.61
Revenue Next Year
$0.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.72
1255.21
52 Week Low
$5.90
$0.28
52 Week High
$13.09
$1.66

Technical Indicators

Market Signals
Indicator
BLMN
LXRX
Relative Strength Index (RSI) 52.27 40.15
Support Level $6.68 $1.29
Resistance Level $7.29 $1.48
Average True Range (ATR) 0.31 0.07
MACD 0.06 -0.01
Stochastic Oscillator 63.47 6.82

Price Performance

Historical Comparison
BLMN
LXRX

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: